Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0008370 (
cholestasis
)
9,378
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The transport processes responsible for bile flow are reviewed. Canalicular bile acid-dependent flow is the result of active transport of bile acids by the hepatocyte into bile canaliculi. Bile acids are taken up by at least two transport systems whose mRNAs have been expressed in Xenopus oocytes: a Na(+)-dependent system, named NTCP, and a Na(+)-independent system, named OATP. Bile acids are then secreted into bile by two other transport systems, an ATP-dependent system and an "electrogenic" voltage-dependent system. It is not known whether these two systems are mediated by the same protein or by two different proteins. Canalicular bile acid-independent flow is mainly the result of the secretion of glutathione into bile. The canalicular membrane contains also several proteins of the
MDR
(Multi Drug Resistance) family. MDR1 is responsible for biliary secretion of cationic drugs. MDR2 plays a major role in the secretion of phospholipids. A third
MDR
related protein has been shown recently to be the canalicular carrier of organic anions, like bilirubin and dyes (the canalicular Multiple Organic Anion Transporter, or cMOAT). Biliary epithelial cells secrete a bicarbonate rich solution, mostly in response to secretion. This secretion depends on the presence on the apical membrane of these cells of the CFTR, a chloride channel activated by cAMP, and of a chloride/bicarbonate exchanger. Knowledge of these transport systems should allow a better understanding of the mechanisms involved in
cholestasis
.
...
PMID:Mechanisms of hepatic transport and bile secretion. 890 66
MDR3 is a hepatocyte canalicular membrane protein encoded by the ABCB4 gene located on chromosome 7. MDR3 mediates the translocation of phosphatidylcholine into bile. Severe
MDR
3 deficiency typically presents during early childhood with chronic
cholestasis
evolving to cirrhosis and portal hypertension, requiring liver transplantation. Herein, we report a case of severe MDR3 deficiency in a male child diagnosed with negative MDR3 immunostaining in hepatic canaliculi who underwent LDLT at our centre. We also describe single incidentally detected early well-differentiated HCC in the explant liver. The patient is on regular follow-up and is doing well. Our report shows that MDR3 deficiency may be a risk factor for the development of HCC.
...
PMID:Hepatocarcinogenesis in multidrug-resistant P-glycoprotein 3 deficiency. 2812 42